SITC Archive Library

On January 11, 2021, leading experts in cancer immunotherapy presented an overview of the recently published "The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guideline on Immunotherapy for the Treatment of Acute Leukemia" during a live webinar.

Webinar Faculty:

• Moderator: Michael M. Boyiadzis, MD, MHSc – University of Pittsburgh (Expert Panel Chair)
• Renier J. Brentjens, MD, PhD – Memorial Sloan-Kettering Cancer Center (Expert Panel Member)
• Jorge M. Cortes, MD – Georgia Cancer Center (Expert Panel Member)
• Mark R. Litzow, MD – Mayo Clinic Cancer Center (Expert Panel Member)

The webinar discussed: 

• SITC's clinical practice guideline on immunotherapy for the treatment of acute leukemia
• The optimal use of approved immunotherapies to improve outcomes for patients with ALL and AML
• Recognition and management of common toxicities with immunotherapy
• Emerging therapies for acute leukemia
• Case studies on the use of immunotherapy for the treatment of acute leukemia

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org.

This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc.

Please note that the on-demand webinar is not available for continuing education credits

#Leukemia #AntibodyDrugConjugates #BispecificAntibodies #Blinatumomab #Tisagenlecleucel #PresentationSlides #RecordedWebinar #Clinician #NursePractitioner #Oncologist #PatientAdvocate #Pharmacist #RegisteredNurse #PhysicianAssistant #ClinicalPracticeGuideline #2021